- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-15-0000239

Atreo Pharmaceuticals Private Limited
About Atreo Pharmaceuticals Private Limited
Data last updated:
Atreo Pharmaceuticals Private Limited is a private limited company based in Kolhapur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U33119PN2019PTC182490. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Prajakta Vijaykumar Mane and Maitreyee Vijaykumar Mane.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1585 Pl No 1 Vimantal Rd Ujlaiwadi Tal Karveer Dist Kolhapur, Maharashtra, India – 416000.
As per the financials filed for FY 2020, the company reported a revenue of ₹33.38 Lakh. For the same year it recorded a net profit of ₹59,651 (net margin 1.8%) and EBITDA of -₹1.54 Lakh (EBITDA margin -4.6%).
Atreo Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-15-0000239). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Atreo Pharmaceuticals
Contact details
Atreo Pharmaceuticals Private Limited's registered office is in Kolhapur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address1585 Pl No 1 Vimantal Rd Ujlaiwadi Tal Karveer Dist Kolhapur, Maharashtra, India – 416000
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Atreo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Atreo Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Atreo Pharmaceuticals Private Limited, buy the company report.
Financials of Atreo Pharmaceuticals Private Limited
FY 2025 filings availableAtreo Pharmaceuticals Private Limited reported revenue of ₹33.38 Lakh for FY 2020.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹33.38 Lakh | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1.54 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹59,651 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -4.6% | |
| Net Profit Margin | 1.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Atreo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Atreo Pharmaceuticals Private Limited
Atreo Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prajakta Vijaykumar Mane Also directs: Ayurvijay Clinics Private Limited, Jeevak Lifesciences Private Limited, Health Book Private Limited and 4 more | Director | 15 Jan 2020 | 6 Years 10 Months | Current |
| Maitreyee Vijaykumar Mane Also directs: Modern Homeopathy Private Limited | Director | 30 Sep 2021 | 5 Years 1 Months | Current |
| Vijaykumar Anandrao Mane Also directs: Ayurvijay Clinics Private Limited, Jeevak Lifesciences Private Limited, Health Book Private Limited and 4 more | Director | 26 Feb 2019 | 7 Years 8 Months | Current |
| Vimal Vijaykumar Mane Also directs: Ayurvijay Clinics Private Limited, Jeevak Lifesciences Private Limited, Health Book Private Limited and 3 more | Director | 26 Feb 2019 | 7 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Atreo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Atreo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Atreo Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Atreo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Atreo Pharmaceuticals Private Limited has 7 board changes on record since 2019: 4 appointments and 3 cessations. The latest: Maitreyee Vijaykumar Mane ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Atreo Pharmaceuticals is an active private limited company based in Kolhapur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 February 2019 (7+ years old) and is registered under CIN U33119PN2019PTC182490.
Atreo Pharmaceuticals has 4 current directors:
- Prajakta Vijaykumar Mane - Director
- Maitreyee Vijaykumar Mane - Director
- Vijaykumar Anandrao Mane - Director
- Vimal Vijaykumar Mane - Director
The latest financial statements of Atreo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
No. Atreo Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Atreo Pharmaceuticals is U33119PN2019PTC182490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atreo Pharmaceuticals was incorporated on 26 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Maitreyee Vijaykumar Mane ceased to be Additional Director on 30 Nov 2021. Maitreyee Vijaykumar Mane was appointed as Director on 30 Sep 2021. Prajakta Vijaykumar Mane ceased to be Additional Director on 30 Dec 2020. Atreo Pharmaceuticals has 7 board changes on record in total.
Yes, Atreo Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-15-0000239).
The registered office of Atreo Pharmaceuticals is at 1585 Pl No 1 Vimantal Rd Ujlaiwadi Tal Karveer Dist Kolhapur, Maharashtra, India – 416000.
Atreo Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

